142 related articles for article (PubMed ID: 15028616)
1. Moxonidine, a mixed alpha(2)-adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia.
Stone LS; Fairbanks CA; Wilcox GL
Ann N Y Acad Sci; 2003 Dec; 1009():378-85. PubMed ID: 15028616
[TBL] [Abstract][Full Text] [Related]
2. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.
Fairbanks CA; Stone LS; Kitto KF; Nguyen HO; Posthumus IJ; Wilcox GL
J Pharmacol Exp Ther; 2002 Jan; 300(1):282-90. PubMed ID: 11752127
[TBL] [Abstract][Full Text] [Related]
3. Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice.
Fairbanks CA; Nguyen HO; Grocholski BM; Wilcox GL
Anesthesiology; 2000 Sep; 93(3):765-73. PubMed ID: 10969310
[TBL] [Abstract][Full Text] [Related]
4. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
5. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors.
Stone LS; Kitto KF; Eisenach JC; Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 2007 Dec; 323(3):899-906. PubMed ID: 17855473
[TBL] [Abstract][Full Text] [Related]
6. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
7. Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.
Shannon HE; Lutz EA
Pain; 2000 Mar; 85(1-2):161-7. PubMed ID: 10692615
[TBL] [Abstract][Full Text] [Related]
8. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
9. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses.
Zhu H; Paul IA; Stec DE; Peeler DF; Piletz JE
Brain Res; 2003 Feb; 964(1):9-20. PubMed ID: 12573508
[TBL] [Abstract][Full Text] [Related]
10. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS
Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
12. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
[TBL] [Abstract][Full Text] [Related]
13. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
Bhalla S; Rapolaviciute V; Gulati A
Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998
[TBL] [Abstract][Full Text] [Related]
14. Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice.
Fairbanks CA; Posthumus IJ; Kitto KF; Stone LS; Wilcox GL
Pain; 2000 Jan; 84(1):13-20. PubMed ID: 10601668
[TBL] [Abstract][Full Text] [Related]
15. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
[TBL] [Abstract][Full Text] [Related]
16. Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.
Sánchez-Blázquez P; Boronat MA; Olmos G; García-Sevilla JA; Garzón J
Br J Pharmacol; 2000 May; 130(1):146-52. PubMed ID: 10781010
[TBL] [Abstract][Full Text] [Related]
17. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
18. The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Koletsky RJ; Velliquette RA; Ernsberger P
Ann N Y Acad Sci; 2003 Dec; 1009():251-61. PubMed ID: 15028595
[TBL] [Abstract][Full Text] [Related]
19. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats.
Glavin GB; Smyth DD
Br J Pharmacol; 1995 Feb; 114(4):751-4. PubMed ID: 7773534
[TBL] [Abstract][Full Text] [Related]
20. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
